Table 5:
Endpoint | PFOA effects | PFOS effects | PFHxS effects | PFAS Mix effects | HFD effects | PFAS+HFD combined effects | |
---|---|---|---|---|---|---|---|
| |||||||
Dams | Litter Size | ↓ w/ PFOA | |||||
BW (PND 21) | ↑ | ↑ | |||||
Liver Weight | ↑ | ↑ | |||||
Serum ALT | ↑ | ↓ w/ PFOA | |||||
Liver TAG | ↓ | ↑ | |||||
Liver Cholesterol | ↑ | ||||||
Serum PFAS | ↓ PFOS | ↑ PFOS | |||||
| |||||||
Pups (PND 21) | Male BW | ↑ | |||||
Female BW | ↓ | ↑ | |||||
Liver Weight | ↑ | ↑ | |||||
Liver Histopathology | ↑ | ||||||
Total Liver Lipid | ↑ | ||||||
Liver TAG | ↑ | ↑ | ↑ | ↑ | ↑ | ↓ w/ all PFAS | |
Liver Cholesterol | ↓ | ||||||
Serum ALT | ↑ | ↑ | ↓ w/ all PFAS | ||||
Serum Leptin | ↑ | ↓ w/ all PFAS | |||||
Male Serum Adiponectin | ↑ | ↑ | |||||
Female Serum Adiponectin | ↓ | ||||||
Serum PFAS | ↓ PFOA | ↓ PFOS | |||||
Liver PFAS | ↓ PFOA | ↓ PFOS | |||||
| |||||||
Pups (PND 90) | Male BW | ↑ | |||||
Female BW | ↑ | ||||||
Male Liver Weight | ↑ | ↑ | |||||
Female Liver Weight | ↑ | ↑ | |||||
Male Serum ALT | ↑ | ↓ w/ all PFAS | |||||
Female Serum ALT | ↑ | ||||||
Female GHbA1c | ↑ | ||||||
Male Serum Leptin | ↑ | ↑ | ↑ | ||||
Female Serum Leptin | ↑ | ||||||
Male Serum Adiponectin | ↑ | ↑ | |||||
Female Serum Adiponectin | ↑ | ↑ | |||||
Male Serum PFAS | ↑ PFOA | ||||||
Female Serum PFAS | ↑ PFOA verse Male | ↑ all PFAS |